Search fresh public links, source activity, and post angles for Progyny In The News.
Fresh curated links around progyny in the news are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Fertility benefit management company Progyny Inc.'s expansion into pregnancy and postpartum care while using the "Progyny" trademark will create confusion in the marketplace by ove...
Progyny has launched Progyny Select, a fully insured fertility benefit designed to help small employers offer comprehensive, cost-predictable family building […] The post Progyny u...
Women's health and fertility company Progyny has unveiled a new fully-insured benefit option that it says will make it easier for small- and mid-size employers to offer fertility c...
A sponsored article during National Infertility Awareness Week on the continued importance of fertility benefits in the workplace. AP The post The new reality of fertility: Why emp...
While the scale of the currency headwinds in Roche’s first-quarter financial update caught many off guard, the company’s earnings call still featured much discussion on a pivotal p...
A new study in sheep models shows that male fetuses exposed to high levels of progesterone experience an accumulation of the SRD5A1 gene in the frontal cortex. These findings empha...
Trung Huynh, an analyst with RBC Capital Markets, has projected Foundayo will reach peak-year sales of $36 billion—14% above the $31.68 billion racked up by last year’s best sellin...
A deal with Rigel Pharmaceuticals ends months of uncertainty about the future of Veppanu, a first-of-its-kind, newly approved medicine with a murky financial outlook.
Polycystic ovary syndrome is now being called polyendocrine metabolic ovarian syndrome (PMOS) following global consensus on a new understanding of what is occurring medically. Dr....
The women’s health benefits market has expanded rapidly and become increasingly fragmented. As workforce needs have evolved, many benefits leaders have found themselves […] The pos...
Decades-long campaign powered by patient perspectives results in switch from PCOS – a name that caused confusion and undue suffering – to PMOS• What is PCOS, what are the symptoms...
What You Should Know Carrot Fertility has expanded Sprints, its AI-native metabolic health program, to support women from perimenopause through post-menopause. The program addresse...
Learn how Preimplantation Genetic Testing (PGT) is revolutionizing fertility care in Nigeria by improving embryo selection and reducing miscarriages. Read More: https://punchng.co...
Known as Veppanu, the drug is the first of its kind to get to market. But Arvinas and partner Pfizer are still searching for a new partner to sell it.
Sun Pharma and Organon said the combined company would rank among the top three in global women’s health, become the world’s seventh‑largest biosimilar player, and operate in 150 c...
On 12 May 2026, one of the most significant renamings in modern medical history appeared in The Lancet. Polycystic Ovary... The post PCOS Is Now PMOS: FemTech Helped Make It Happen...
Written by the Progyny Editorial Team. Reviewed by the Progyny Clinical Team – April 2026. Pelvic floor physical therapy (PT) […] The post Starting pelvic floor therapy in the firs...
FRIDAY, May 15, 2026 — A major women’s health condition is getting a new name—and experts say it could change how millions are diagnosed and treated worldwide. Polycystic ovary syn...
After years of confusing symptoms including weight changes, irregular periods and unwanted facial hair growth, millions of women finally have a clearer path to understanding their...
"The condition formerly known as PCOS now has a new name: polyendocrine metabolic ovarian syndrome," says a new paper published yesterday in The Lancet.
The company hopes to keep adding more brand-name products, including the Zepbound KwikPen, as they become available.
Medicus Pharma to present Phase 1 Teverelix data showing dose-dependent estradiol suppression and long-acting profile at AACE 2026. Importance Rank: ...
At a Glance: Patients can now access coordinated care across the GenPrime network in Singapore, Bangkok, Manila, and Los Angeles, making it easier to... The post GenPrime Everlink...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.